Implementing HEARTS in Guatemala
Implementing Integrated Diabetes and Hypertension Management in Guatemala Using the HEARTS Model
2 other identifiers
interventional
964
1 country
1
Brief Summary
The HEARTS Technical Package was developed by the World Health Organization to address the implementation gap of cardiovascular disease prevention in low- and middle-income countries. Guatemala is a middle-income country that is currently implementing HEARTS. National authorities are interested in exploring how hypertension and diabetes management can be integrated in HEARTS implementation. The objective of this study is to conduct a feasibility and acceptability pilot trial of integrated hypertension and diabetes management based on HEARTS in the publicly funded primary care system in Guatemala.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Oct 2023
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 3, 2023
CompletedFirst Submitted
Initial submission to the registry
October 6, 2023
CompletedFirst Posted
Study publicly available on registry
October 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 27, 2024
CompletedResults Posted
Study results publicly available
June 19, 2025
CompletedJune 19, 2025
June 1, 2025
8 months
October 6, 2023
February 26, 2025
June 17, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Score on Feasibility of Intervention Measure (FIM) Questionnaire
Feasibility will be assessed among Ministry of Health (MOH) participants through the four-item Feasibility of Intervention Measure (FIM) Questionnaire and semi-structured interviews. A Spanish-language version of the FIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.
6 months
Number of Target Health Districts That Met Enrollment Goals
This study will be working with two different health districts, one in the west and the other in the east. This measure is the number of districts that met enrollment goals for patients for patients with diabetes (at least 25) and also for patients with hypertension (at least 25). A given patient may have both diabetes and hypertension and thus count toward each benchmark
6 months
Score on Acceptability of Intervention Measure (AIM) Questionnaire
Acceptability will be assessed among providers through the four-item Acceptability Intervention Measure (AIM) Questionnaire and semi-structured interviews. A Spanish-language version of the AIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.
6 months
Proportion of Patient Participants With Subsequent Follow-up Visit Within 3 Months
Proportion of patient participants with subsequent follow-up visit within 3 months in both regions combined.
3 months
Secondary Outcomes (15)
Hypertension Treatment Rate
6 months
Diabetes Treatment Rate
6 months
Proportion of Patient Participants Achieving Glycemic Control
6 months
Proportion Achieving Control of Blood Pressure
6 months
Adoption
6 months
- +10 more secondary outcomes
Study Arms (2)
HEARTS implementation - Patients
EXPERIMENTALA trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the patients whose health markers will be monitored through the study.
HEARTS implementation - Providers
EXPERIMENTALA trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
Interventions
The intervention consists of five components that align with the World Health Organization Technical Package for Cardiovascular Disease Management in primary Health Care. 1. Training health workers on diabetes and hypertension treatment protocols 2. Team-based care and task sharing 3. Strengthening access to medications and diagnostics 4. Electronic medical record system and registry 5. Systems monitoring and feedback of key indicators
The intervention consists of five components that align with the World Health Organization Technical Package for Cardiovascular Disease Management in primary Health Care. 1. Training health workers on diabetes and hypertension treatment protocols 2. Team-based care and task sharing 3. Strengthening access to medications and diagnostics 4. Electronic medical record system and registry 5. Systems monitoring and feedback of key indicators Health care providers will administer this intervention to patient participants and will report on their experience.
Eligibility Criteria
You may qualify if:
- Non-pregnant adults aged ≥18 years
- Diagnoses of type 2 diabetes or hypertension
- Present for routine care at participating MOH primary health facilities
You may not qualify if:
- Confirmed or suspected type 1 diabetes
- Pregnant
- Are not managed at MOH health centers or health posts
- Provider/other participants
- Participation in delivering HEARTS or on the Technical Advisory Committee
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- Institute of Nutrition of Central America and Panamacollaborator
- Ministry of Health, Guatemalacollaborator
Study Sites (1)
Ministry of Health clinics
San Pablo La Laguna, Departamento de Sololá, Guatemala
Related Publications (2)
Wellmann IA, Ayala LF, Rodriguez JJ, Guetterman TC, Irazola V, Palacios E, Huffman MD, Rohloff P, Heisler M, Ramirez-Zea M, Flood D. Implementing integrated hypertension and diabetes management using the World Health Organization's HEARTS model: protocol for a pilot study in the Guatemalan national primary care system. Implement Sci Commun. 2024 Jan 9;5(1):7. doi: 10.1186/s43058-023-00539-8.
PMID: 38195600BACKGROUNDWellmann IA, Ayala LF, Valley TM, Irazola V, Huffman MD, Heisler M, Rohloff P, Donis R, Palacios E, Ramirez-Zea M, Flood D. Evaluating the World Health Organization's Hearts Model for Hypertension and Diabetes Management: A Pilot Implementation Study in Guatemala. Glob Heart. 2025 Jan 31;20(1):9. doi: 10.5334/gh.1397. eCollection 2025.
PMID: 39896314RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. David Flood
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
David Flood, MD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine
Study Record Dates
First Submitted
October 6, 2023
First Posted
October 12, 2023
Study Start
October 3, 2023
Primary Completion
May 27, 2024
Study Completion
May 27, 2024
Last Updated
June 19, 2025
Results First Posted
June 19, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
This project will produce multiple types of data, including patients' clinical information, health facility assessments, and structured and semi-structured interviews. Deidentified data, analytic code, and data dictionaries will be made available on the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) data repository (https://biolincc.nhlbi.nih.gov/) after the study concludes. Semi-structured interview transcripts and structured questionnaire data will not be shared due to privacy concerns and risk for re-identification.